PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1933161

Gluteal device for penile injection.

A M Helmy
View original source ↗Export metadata ↓

Abstract

Locally acting vasodilator drugs have been used in the treatment of male impotence. Self injection, which may be most suitable in these circumstances, often presents difficulties. An implantable device was therefore used to make self injection possible for a wider selection of patients and 37 have now been treated successfully between January 1987 and September 1988.

Explore related subjects

Drug Therapy, CombinationErectile DysfunctionHumansInfusion Pumps, ImplantableMaleMethodsPapaverinePenile ErectionPhentolamineJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A M Helmy. 1991. Gluteal device for penile injection.. https://doi.org/10.1111/j.1464-410x.1991.tb15360.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus].

According to the NIH scheme, the "evidence based medicine" standard in the treatment of severe proliferative lupus-nephritis is cyclophosphamide in combination with steroids. Undesired effects, therapy resistance, and deficient long-term effects underscore the necessity for the development of alternative therapies for the treatment of organ involvement. Mycophenolate mofetil (MMF) possesses the potential to decisively improve the therapeutic possibilities for systemic lupus erythematosus (SLE). On the basis of the available data, MMF represents an alternative to the current standard therapies for severe lupus-nephritises and shows less toxicity. MMF is also effective in patients with other manifestations refractory to conventional therapy. Questions remain unanswered on the optimal dosage and possible reduction in cases of remission. In addition, the duration of maintenance therapy is unclear. Therefore, large, prospective, randomized clinical studies in the treatment of lupus-nephritis with a sufficiently long follow-up phase are underway.

Drug Therapy, Combination↗